RT Journal Article
SR Electronic
T1 P27. Alemtuzumab (anti-CD52 monoclonal antibody) as single-agent therapy in patients with relapsed/refractory chronic lymphocytic leukaemia (CLL) – a single region experience on consecutive patients
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP P18
DO 10.1186/2051-1426-2-S2-P18
VO 2
IS Suppl 2
A1 Sylvan, S Eketorp
A1 Lundin, J
A1 Ipek, M
A1 Palma, M
A1 Karlsson, C
A1 Hansson, L
YR 2014
UL http://jitc.bmj.com/content/2/Suppl_2/P18.abstract